Literature DB >> 23644221

Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction.

Xiaoxiang Yan1, Atsushi Anzai, Yoshinori Katsumata, Tomohiro Matsuhashi, Kentaro Ito, Jin Endo, Tsunehisa Yamamoto, Akiko Takeshima, Ken Shinmura, Weifeng Shen, Keiichi Fukuda, Motoaki Sano.   

Abstract

Acute myocardial infarction (MI) causes sterile inflammation, which is characterized by recruitment and activation of innate and adaptive immune system cells. Here we delineate the temporal dynamics of immune cell accumulation following MI by flow cytometry. Neutrophils increased immediately to a peak at 3 days post-MI. Macrophages were numerically the predominant cells infiltrating the infarcted myocardium, increasing in number over the first week post-MI. Macrophages are functionally heterogeneous, whereby the first responders exhibit high expression levels of proinflammatory mediators, while the late responders express high levels of the anti-inflammatory cytokine IL-10; these macrophages can be classified into M1 and M2 macrophages, respectively, based on surface-marker expression. M1 macrophages dominated at 1-3 days post-MI, whereas M2 macrophages represented the predominant macrophage subset after 5 days. The M2 macrophages expressed high levels of reparative genes in addition to proinflammatory genes to the same levels as in M1 macrophages. The predominant subset of dendritic cells (DCs) was myeloid DC, which peaked in number on day 7. Th1 and regulatory T cells were the predominant subsets of CD4(+) T cells, whereas Th2 and Th17 cells were minor populations. CD8(+) T cells, γδT cells, B cells, natural killer (NK) cells and NKT cells peaked on day 7 post-MI. Timely reperfusion reduced the total number of leukocytes accumulated in the post-MI period, shifting the peak of innate immune response towards earlier and blunting the wave of adaptive immune response. In conclusion, these results provide important knowledge necessary for developing successful immunomodulatory therapies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ASC; DAMPs; DC; Damage-associated molecular patterns; Dendritic cell; Flow cytometry; IR; Immune response; Ischemia–reperfusion; Jmjd3; Jumonji domain containing 3; Klf4; Kruppel-like factor 4; LV; Left ventricular; Macrophage polarity; Myocardial infarction; Pycard; Regulatory T cell; Reperfusion therapy; Treg

Mesh:

Substances:

Year:  2013        PMID: 23644221     DOI: 10.1016/j.yjmcc.2013.04.023

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  187 in total

1.  YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction.

Authors:  Masum M Mia; Dasan Mary Cibi; Siti Aishah Binte Abdul Ghani; Weihua Song; Nicole Tee; Sujoy Ghosh; Junhao Mao; Eric N Olson; Manvendra K Singh
Journal:  PLoS Biol       Date:  2020-12-02       Impact factor: 8.029

2.  Inhibition of programmed necrosis limits infarct size through altered mitochondrial and immune responses in the aged female rat heart.

Authors:  Alexandra M Garvin; Morgan A Jackson; Donna H Korzick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-29       Impact factor: 4.733

3.  Wnt5a-Mediated Neutrophil Recruitment Has an Obligatory Role in Pressure Overload-Induced Cardiac Dysfunction.

Authors:  Ying Wang; Soichi Sano; Kosei Oshima; Miho Sano; Yosuke Watanabe; Yasufumi Katanasaka; Yoshimitsu Yura; Changhee Jung; Atsushi Anzai; Filip K Swirski; Noyan Gokce; Kenneth Walsh
Journal:  Circulation       Date:  2019-06-07       Impact factor: 29.690

4.  Deriving a cardiac ageing signature to reveal MMP-9-dependent inflammatory signalling in senescence.

Authors:  Yonggang Ma; Ying Ann Chiao; Ryan Clark; Elizabeth R Flynn; Andriy Yabluchanskiy; Omid Ghasemi; Fouad Zouein; Merry L Lindsey; Yu-Fang Jin
Journal:  Cardiovasc Res       Date:  2015-04-15       Impact factor: 10.787

5.  Defensin-chemokine heteromeric complexes derived from heterocellular activation-a possible target to inhibit CCL5 in cardiovascular settings.

Authors:  Osamu Baba; Yongjian Liu; Gwendalyn J Randolph
Journal:  Ann Transl Med       Date:  2016-12

6.  Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury.

Authors:  Luigi Adamo; Lora J Staloch; Cibele Rocha-Resende; Scot J Matkovich; Wenlong Jiang; Geetika Bajpai; Carla J Weinheimer; Attila Kovacs; Joel D Schilling; Philip M Barger; Deepta Bhattacharya; Douglas L Mann
Journal:  JCI Insight       Date:  2018-06-07

Review 7.  Innate immunity as a target for acute cardioprotection.

Authors:  Coert J Zuurbier; Antonio Abbate; Hector A Cabrera-Fuentes; Michael V Cohen; Massimo Collino; Dominique P V De Kleijn; James M Downey; Pasquale Pagliaro; Klaus T Preissner; Masafumi Takahashi; Sean M Davidson
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

Review 8.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

9.  It takes two to tango: monocyte and macrophage duality in the infarcted heart.

Authors:  Sumanth D Prabhu
Journal:  Circ Res       Date:  2014-05-09       Impact factor: 17.367

10.  Regeneration-associated cells improve recovery from myocardial infarction through enhanced vasculogenesis, anti-inflammation, and cardiomyogenesis.

Authors:  Amankeldi A Salybekov; Akira T Kawaguchi; Haruchika Masuda; Kosit Vorateera; Chisa Okada; Takayuki Asahara
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.